Open Access
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
Cancer DiscoveryPeer ReviewedKeith T. Flaherty +62021Journals
Summary: The COVID-19 pandemic brought about major changes in cancer clinical trials. In its aftermath, the community has an opportunity to incorporate some of these changes as part of the future of trial conduct to make it more patient centered.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support